After meeting with President Trump separately, Presidents Putin and Zelenskiy could be headed toward a pivotal face-to-face meeting to begin peace talks. But what each side is willing to give up to end the Russia-Ukraine war remains to be seen.

On today’s Big Take podcast, David Gura sits down with Bloomberg’s White House correspondent Justin Sink and Europe government editor Piotr Skolimowski to discuss Russia and Ukraine’s red lines and the role the US and Europe could play in guaranteeing a ceasefire.

See omnystudio.com/listener for privacy information.

At this point in the war between Israel and Hamas, it’s difficult to get more than anecdotal evidence out of Gaza. Almost every organization that once provided aid and monitored civilian welfare is no longer allowed in — or has ceased operations. Very few journalists are left there.

But reports of a civilian population facing a hunger crisis are widespread.

To understand the reality on the ground, host David Gura talked to Bloomberg’s Israel bureau chief Ethan Bronner, UN reporter Magdalena Del Valle and Gaza reporter Fares Alghoul to understand how a hunger crisis unfolded there despite months of warnings.

Read more:

How Gaza Descended Into a Hunger Crisis, Explained

Israel Intends to Fully Take Over Gaza Despite Global Isolation

See omnystudio.com/listener for privacy information.

When a shortage of brand-name weight-loss drugs like Ozempic and Wegovy cleared the way for companies like Hims to fill the gap with cheaper, compounded versions, customers came flocking. But in February, the US Food and Drug Administration announced the shortage was over, leaving the company's strategy in flux and some investors worried.

On today’s Big Take podcast, host David Gura and Bloomberg healthcare reporter Madison Muller track how Hims became the king of copycat weight-loss drugs and what’s next for the company as it fights to hold onto the crown.

Read more: How Hims Became the King of Knockoff Weight-Loss Drugs

Cheap Ozempic Knockoffs Are Suddenly Everywhere. Are They Safe?

The Weight-Loss Drug Boom’s Prescription Problem

Listen and follow The Big Take on Apple Podcasts, Spotify or wherever you get your podcasts.

See omnystudio.com/listener for privacy information.